Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
Margaret Cristina da Silva Boguszewski(Universidade Federal do Paraná), Gudmundur Johannsson(Sahlgrenska University Hospital), Claire Higham(Manchester Academic Health Science Centre), Sally Radovick(Johns Hopkins University), Hermann L. Müller(Klinikum Oldenburg), Alberto Fernández(Hospital Universitario de Móstoles), P. Pennisi(Consejo Nacional de Investigaciones Científicas y Técnicas), Vera Popović(University of Belgrade), Xiaoping Luo(Huazhong University of Science and Technology), Nathalie Alos(Centre Hospitalier Universitaire Sainte-Justine), Adriane Cardoso-Demartini(Hospital de Clínicas Universidade Federal do Paraná), Judith Gebauer(University Hospital Schleswig-Holstein), Peter Clayton(University of Manchester), Lars Sävendahl(Karolinska Institutet), Maya Lodish(University of California, San Francisco), Manoel H Aguiar Oliveira(Universidade Federal de Sergipe), Kevin C.J. Yuen(Swedish Medical Center), Philippe Touraine(Inserm), Ken K. Y. Ho(Garvan Institute of Medical Research), Hanneke M. van Santen(Wilhelmina Children's Hospital), John J. Kopchick(Biotechnology Institute), Adda Grimberg(University of Pennsylvania), Martin Bidlingmaier(Ludwig-Maximilians-Universität München), César Luiz Boguszewski(Universidade Federal do Paraná), Laurie E. Cohen(Boston Children's Hospital), Kolbeinn Guðmundsson(National University Hospital of Iceland), Шломо Мелмед(Cedars-Sinai Medical Center), Stefano Cianfarani(University of Rome Tor Vergata), Michel Polak(Délégation Paris 5), Niki Karavitaki(University Hospitals Birmingham NHS Foundation Trust), Wassim Chemaitilly(St. Jude Children's Research Hospital), Beverley M K Biller(Massachusetts General Hospital), Keiichi Ozono(The University of Osaka), Jaime Guevara‐Aguirre(Universidad San Francisco de Quito), Peter Kamenický(Université Paris-Sud), R. Coutant(Centre Hospitalier Universitaire d'Angers), Lillian R. Meacham(Children's Healthcare of Atlanta), Zoltan Antal(Memorial Sloan Kettering Cancer Center), Jens Otto Lunde Jørgensen(Aarhus University), Ann McCormack(Garvan Institute of Medical Research), George Brabant(University of Manchester), Andrea M. Isidori(Sapienza University of Rome), Sebastian J C M M Neggers(Erasmus University Rotterdam), Catherine S Choong(The University of Western Australia), Reiko Horikawa(National Center For Child Health and Development), Sogol Mostoufi‐ Moab(Children's Hospital of Philadelphia), Andrew R. Hoffman(VA Palo Alto Health Care System)
Cited by 111
Related Papers
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
|Hormone Research in Paediatrics|2015|3.1k
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)
|The Lancet|2017|856
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763